Trade Bristol Myers BMY

BristolMyers live chart

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

BristolMyers News

Ghko B 2026 Mar 12, 16:01

Adani Total Gas stock (ATGL) surged 37% in two days: What's going on with gas prices?

Ghko B 2026 Mar 12, 16:01

Starbucks (SBUX) shares analysis: Is Starbucks a good stock to buy right now?

Ghko B 2026 Mar 12, 16:01

Will Nvidia (NVDA) stock hit $300: What is the NVDA price prediction for 2030?

Frances Wang 2026 Mar 12, 16:01

SES AI Corp stock analysis: Why SES stock is trading down today?

Ghko B 2026 Mar 12, 16:01

How to buy the top AI stocks in the Emirates: Microsoft (MSFT), Nvidia (NVDA), Alphabet stock

Ghko B 2026 Mar 11, 16:02

The Vanguard S&P 500 ETF is popular: Is VOO a good ETF to invest in?

Frances Wang 2026 Mar 11, 16:01

Forex Market Analysis: JPY/USD, CHF/USD, EUR/USD, GBP/USD

Ghko B 2026 Mar 11, 16:01

Most active stocks analysis: NVIDIA (NVDA), Tesla (TSLA), Amazon (AMZN) stock

Ghko B 2026 Mar 11, 16:01

A beginner's guide to investing in stocks: How to buy NVDA stock in United Arab Emirates?

Frances Wang 2026 Mar 10, 16:01

Commodity market today: UAE gold prices swing, what factors affect the price of gold?

Latest news

Show more
Noah Lee 2025 Dec 06, 17:50

ESMA Expansion Sparks Crypto, Fintech Slowdown Concerns in EU

Noah Lee 2025 Dec 06, 17:00

Bitcoin's 'Santa' Rally: Fed Rate Decision and 2026 Outlook

Liam James 2025 Dec 06, 12:40

Western Union Unveils Stable Card, Stablecoin Strategy to Combat Inflation

Ava Grace 2025 Dec 06, 11:50

Market Movers: Fed Rate Decision & Key Economic Data in Focus Next Week

Noah Lee 2025 Dec 06, 10:50

Central Bank Rate Decisions & Market Volatility Outlook: What to Expect

Emma Rose 2025 Dec 06, 09:40

Clear Street Prepares for IPO Amid Crypto Treasury Model Concerns

Ava Grace 2025 Dec 06, 09:30

Crypto Market Analysis and Regulatory Updates: December 6, 2024

Sophia Claire 2025 Dec 06, 08:00

Bitcoin Treasury Firms Face 'Darwinian Phase' Amid Market Shift

Info

Spread

0.38

Spread (%)

0.6457 %

Leverage

1:10

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Monday

13:31 - 19:59

Tuesday

13:31-19:59

Wednesday

13:31-19:59

Thursday

13:31-19:59

Friday

13:31-19:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

120050130944

Shares Outstanding

2036473705

Earnings Date (Next)

2001-08-07

Div Yield

2026-05-01

Ex-Dividend Date

2026-04-02

Forward annual dividend rate

2.52

Forward annual dividend yield

0.042

EPS

3.46

Learn more about this instrument

Bristol Myers Bristol-Myers Squibb Company
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for oncology, hematology, immunology, cardiovascular, neuroscience, and other areas. The company's products include Opdivo for various anti-cancer indications; Opdivo Qvantig, a subcutaneous PD-1 inhibitor for solid tumorsr; Orencia for active rheumatoid arthritis and psoriatic arthritis; Yervoy for the treatment of patients with unresectable or metastatic melanoma; Reblozyl to treat anemia; Breyanzi for the treatment of patients with relapsed or refractory large B-cell lymphoma; Opdualag for the treatment of unresectable or metastatic melanoma; and Camzyos to treat symptomatic obstructive HCM to improve functional capacity and symptom. It also offers Zeposia to treat relapsing forms of multiple sclerosis; Abecma for the treatment of patients with relapsed or refractory multiple myeloma; Sotyktu for the treatment of moderate-to-severe plaque psoriasis; Krazati for the treatment of adult patients with KRASG12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC); and Cobenfy to treat schizophrenia. In addition, it offers Eliquis for a reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation and for the treatment of DVT/PE; Revlimid, an oral immunomodulatory drug to treat multiple myeloma; Pomalyst/Imnovid for multiple myeloma; Sprycel for Philadelphia chromosome-positive chronic myeloid leukemia; and Abraxane for the treatment of breast cancer. Further, it provides Augtyro for the treatment of locally advanced or metastatic ROS1-positive NSCLC; and NSCLC and pancreatic cancer. It sells products to wholesalers, distributors, specialty pharmacies, and to a lesser extent, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. The company was founded in 1887 and is headquartered in Princeton, New Jersey.

Related Instruments

Asset
Sell
Buy
Change (%)
View all instruments

Latest Education Articles

Show more
Ghko B 2026 Mar 11, 16:01

Gold prices today in the UAE: How to begin investing in gold in the UAE?

Ghko B 2026 Mar 02, 16:00

Learn to trade: buy/sell stock CFDs online, how to invest in stocks in UAE?

Ghko B 2026 Mar 01, 16:00

CFD Trading & Markets: How do I register for CFD trading in the United Arab Emirates (UAE)?

Trustpilot